Oncogenesis - 

Loss of <i>HAT1</i> expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R

Oncogenesis, Published online: 05 May 2020; doi:10.1038/s41389-020-0228-xLoss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R

Oncogenesis - nature.com science feeds

Tue May 05, 2020 03:00

Loss of <i>HAT1</i> expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R

Oncogenesis - nature.com science feeds

Tue May 05, 2020 03:00

Mark above section as read